MicroRNA expression profiling in acute kidney injury

Akinori Aomatsu1, Shohei Kaneko2, Katsunori Yanai2

  • 1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Division of Intensive Care Unit, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

Insights

Researchers identified miRNA-5100 as a key regulator of acute kidney injury (AKI). Lowered miRNA-5100 levels in AKI patients suggest its potential as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a critical clinical condition with limited diagnostic and therapeutic options.
  • MicroRNAs (miRNAs) are emerging as key regulators in various biological processes, including kidney injury.

Purpose of the Study:

  • To identify novel miRNAs involved in AKI pathogenesis.
  • To explore the diagnostic and therapeutic potential of identified miRNAs in AKI.

Main Methods:

  • Microarray analysis and quantitative RT-PCR were used to screen miRNA expression in two mouse models of AKI (LPS-induced and IRI-induced).
  • miRNA-5100 mimic conjugated with polyethylenimine nanoparticles (PEI-NPs) was administered to investigate therapeutic effects in vivo.
  • Serum miRNA levels were analyzed in AKI patients using ROC analysis.

Main Results:

  • miRNA-5100 expression was significantly decreased in the kidneys of both AKI mouse models.
  • Overexpression of miRNA-5100 using PEI-NPs inhibited apoptosis pathways and protected against renal ischemia-reperfusion injury (IRI-AKI) in mice.
  • Serum levels of miRNA-5100 were significantly lower in AKI patients compared to healthy subjects.
  • Serum miRNA-5100 demonstrated high accuracy in diagnosing AKI (AUC=0.96).

Conclusions:

  • miRNA-5100 plays a regulatory role in AKI.
  • miRNA-5100 is a promising diagnostic biomarker for AKI.
  • miRNA-5100 represents a potential therapeutic target for AKI treatment.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
180
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
132
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
80
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
173
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
109